Press Releases GSK plc

Equities

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. Other stock markets 19:35:19 15/05/2026 +04			5-day change	1st Jan Change
1,862.50 ^GBX	-0.53%		+1.06%	+2.08%

05-15	WINNERS & LOSERS: Miners slide; Centrica to pay GBP20 million to Ofgem	AN
05-14	Morningstar Upgrades GSK to Buy Rating	MT

Press Releases

05-11	GSK : enters exclusive collaboration with SBP Group, a market leader in hepatology in China, to accelerate bepirovirsen at launch	PU
05-07	Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults	BU
05-06	GSK : 2026 Remuneration Policy	PU
05-06	GSK : presents latest respiratory research to advance patient care at ATS 2026	PU
04-30	GSK : Q1 2026 results transcript	PU
04-29	The Fifth International Healthcare Week set for next month	AQ
04-29	Glaxo: Q1 Earnings Snapshot	AQ
04-29	GSK : Q1 2026 results slides	PU
04-29	GSK : Q1 2026 pipeline assets and clinical trials report	PU
04-29	GSK : Q1 2026 results infographic	PU
04-29	GSK : Q1 2026 US dollar translation	PU
04-29	GSK : delivers strong Q1 performance and start to 2026	PU
04-28	GSK : Bepirovirsen accepted for priority review and granted Breakthrough Therapy Designation by the US FDA	PU
04-27	GSK : investigational liver therapy, efimosfermin, receives US FDA Breakthrough Therapy and EMA Priority Medicines (PRIME) designations for MASH	PU
04-12	GSK : presents positive data for B7-H4-targeted ADC in gynaecological cancers	PU
04-10	The Time to Talk about HIV is Now: ViiV Healthcare Launches "Still Here" PSA to Ignite Action Around HIV on National Youth HIV/AIDS Awareness Day	BU
04-09	GSK : Q1 2026 pre announcement aide memoire	PU
03-30	GSK plc - Bepirovirsen accepted for review by the European Medicines Agency as a potential first-in-class treatment for chronic hepatitis B	AQ
03-25	GSK : Articles of Association - Proposed Amendments	PU
03-25	GSK : Proxy Form 2026	PU
03-25	GSK : Notice of AGM 2026	PU
03-23	GSK : B7-H3-targeted antibody-drug conjugate, risvutatug rezetecan, granted Orphan Drug Designation for small-cell lung cancer in Japan	PU
03-17	Eastern District Of Pennsylvania Dismisses Putative Securities Class Action Against Pharmaceutical Company As Time-Barred	AQ
03-16	GSK's RSV vaccine, Arexvy, approved in US for expanded age indication in adults aged 18-49 years at increased risk	AQ
03-13	GlaxoSmithKline Egypt profit rises 22.5% y/y to $4.07mn in 2025	AQ